中度/重度发育迟缓/智力障碍,丰富的表型异质性的儿科患者的染色体异常:单中心研究

Dan Wu1, Yi Wu2, Yulong Lan3

  • 1Department of Pediatrics, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.

Pediatric neurology
|August 11, 2023
PubMed
概括

染色体微阵列 (CMA) 在诊断中度至重度发育迟缓/智力障碍 (DD/ID) 中在中国儿科患者中具有临床有用性. 随着先天性异常的增加,观察到更高的诊断产量,支持CMA作为一级测试.